Oncology

Latest News

Video Series

Overcoming Barriers to TIL Use in Patients With Solid Tumors

TIL Therapy: Lessons Learned and Potential Future Directions in Care

Data from Additional Clinical Studies on Tumor-Infiltrating Lymphocyte Therapy

Results From the C-144-01 Trial and Potential Impact on Clinical Practice

Tumor-Infiltrating Lymphocyte Therapy: Clinical Data on Biologic Activity

Clinical Experience With TIL Therapy for Solid Tumors

Considerations for Use of TILs versus CAR T-cell Therapies

An Overview on Tumor-Infiltrating Lymphocyte Therapy for Solid Tumors

Latest Videos

Interview Highlights From ASH's 2025 Meeting

Deevyashali Parekh, MBBS, an internal medicine resident at SUNY Upstate Medical University Hospital

Deevyashali Parekh, MBBS, on Evaluating CAR-T in Patients With Multiple Myeloma and Renal Failure

Janna Minehart, MD, a clinical fellow in hematology oncology (Master of Science Translational Research Program) at the University of Pennsylvania

Janna Minehart, MD, on Hematology-Oncology Immunotherapy Highlights at ASH 2025

Prerna Mewawalla, MD, medical director of Apheresis and a hematologist-oncologist in the Division of Hematology and Cellular Therapy at Allegheny Health Network, as well as an associate professor at the Drexel University College of Medicine.

Prerna Mewawalla, MD, on Unmet Needs Following Early-Line CAR T for R/R Multiple Myeloma

Surbhi Sidana, MD, an assistant professor of medicine, bone marrow transplantation, and cellular therapy at Stanford

Surbhi Sidana, MD, on Cilta-Cel's Efficacy in Second-Line Relapsed/Refractory Multiple Myeloma

Alexey Danilov, MD, PhD, the Marianne and Gerhard Pinkus Professor of Early Clinical Therapeutics, medical director of the Early Phase Therapeutics Program for the Systems Clinical Trials Office, codirector of the Toni Stephenson Lymphoma Center, and a professor in the Division of Lymphoma in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, California

Alexey Danilov, MD, PhD, on CAR T and Bispecific Antibody Sequencing for DLBCL

Matthew Ku, MBBS, FRACP, RACP, FRCPA/RCPA, PhD, an associate professor and the lymphoma stream lead at St Vincent’s Hospital

Matthew Ku, MBBS, PhD, FRACP, RACP, FRCPA/RCPA, on CAR T-Cell Therapy JNJ-90014496's Safety Profile in R/R LBCL

Saurabh Dahiya, MD, FACP, an associate professor of medicine at Stanford University School of Medicine; as well as clinical director of Cancer Cell Therapy in the Division of Blood and Marrow Transplantation and Cell Therapy at Stanford Medicine

Saurabh Dahiya, MD, FACP, on CAR-T KITE-363's Safety Profile in R/R B-Cell Lymphoma

Shahzad Raza, MD, a hematologist/oncologist at the Cleveland Clinic

Shahzad Raza, MD, on Future Plans for CAR T-Cell Therapy NXC-201 in R/R Light Chain Amyloidosis

Manali Kamdar, MD, the associate professor of medicine–hematology and clinical director of lymphoma services at the University of Colorado

Manali Kamdar, MD, on Lowering Barriers to Access for Liso-Cel Based on New Data

Shorts

1:19

The Challenge of T-Cell Therapy Timing

2 months ago

0:31

Bad T-cells lead to failed cancer treatments

2 months ago

0:42

Why One Target Isn't Enough: The Future of Neuroblastoma Therapy

2 months ago

2:20

'Paintable' CAR T-Cells

4 months ago

0:53

Can we omit chemotherapy in breast cancer treatment?

4 months ago

0:38

Does Immunotherapy Work Better Before Surgery?

4 months ago

2:02

The key role of manufacturing in cell therapy success

5 months ago

1:19

TIL expansion and more in vivo CAR data in 2026?

5 months ago

1:13

What CGT indications do you think will make major progress in 2026?

5 months ago

1:24

Thoughts on Cilta-Cel's Boxed Warning

5 months ago

Podcasts

April 3, 2026

ImmunoLogic, Episode 9: "Rewiring Immunotherapy for High-Risk Neuroblastoma" With Kristopher R. Bosse, MD

February 10, 2026

ImmunoLogic, Episode 8: "Surgery Meets Immunotherapy: A One-Two Punch for Breast Cancer" With Julia C. Tchou, MD, PhD, FACS

January 2, 2026

ImmunoLogic, Bonus Episode: "Chemo Optional, Data Mandatory - A Year-End Recap"

December 24, 2025

ImmunoLogic, Bonus Episode: "ASH 2025: Practice-Changers on the Ground and on the Wi‑Fi"

December 2, 2025

ImmunoLogic, Episode 7: "Turbocharging CAR T-Cells: The IL-9 Orthogonal Signal" With Anusha Kalbasi, MD

November 4, 2025

Quarter Century Update: The Impact of Artificial Intelligence

October 31, 2025

Quarter Century Update: Thoughts on Reducing Costs of Goods

October 30, 2025

Quarter Century Update: Future Predictions for the Field

October 29, 2025

Quarter Century Update: What Does the Field Need Most Right Now?

October 29, 2025

Quarter Century Update: What Lessons Should Guide the Next Generation of Developers and Regulators?

CME Content

Virtual Event

Wyoming State Oncology Society

2 Sessions are Available!

Virtual Event

Tennessee Oncology Practice Society

2 Sessions are Available!

Virtual Event

North Carolina Oncology Association

2 Sessions are Available!

Video

Cases and Conversations: Applying the Evidence – Real-World Strategies to Optimize Care for Patients With Myelofibrosis

Ruben A. Mesa, MD, FACP; Andrew Kuykendall, MD; Sangeetha Venugopal, MD, MS

Virtual Event

Oncology Town Hall: Insights Reshaping How We Treat MPNs From the 2026 Summer Oncology Meetings

June 29, 2026

Video

Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia

Gabriela Hobbs, MD; Rami Komrokji, MD; Douglas A. Tremblay, MD

$(CME Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas$

Video

(CME Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas

Lori A. Leslie, MD; Alex Mejia, MD

Virtual Event

Cases and Conversations: Adopting New Treatment Strategies in Polycythemia Vera and Essential Thrombocythemia

July 8, 2026

Video

Cases & Conversations™: Transforming AML Care—Precision Strategies, Evolving Therapies, and Clinical Insights

Gail J. Roboz, MD; Hagop Kantarjian, MD; Catherine Lai, MD, MPH; Amer Zeidan, MBBS, MHS

$Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma$

Video

Cases and Conversations™: Sorting Through the Expanding Treatment Options for Patients with Relapsed/Refractory Multiple Myeloma

C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD

Video

Medical Crossfire®: Improving Patient Outcomes in Myeloproliferative Neoplasms With Novel Therapeutic Approaches

Rami Komrokji, MD; Gabriela Hobbs, MD; John Mascarenhas, MD; Naveen Pemmaraju, MD

Video

Medical Crossfire®: Harnessing the Power of Modern Therapies in Newly Diagnosed Multiple Myeloma

C. Ola Landgren, MD, PhD; Mohamad Mohty, MD, PhD; Surbhi Sidana, MD

In-Person + Virtual Event

10th Annual Live Medical Crossfire®: Hematologic Malignancies

July 11-12, 2026

Virtual Event

A Community-Based Roadmap to CAR-T Therapy: Optimizing Delivery and Outcomes

4-Part Webinar Series

Virtual Event

Kentucky Society of Clinical Oncology

2 Sessions are Available!

Video

Expert Perspectives on Applying Recent Evidence to Practice in the Management of Newly Diagnosed Multiple Myeloma

Amrita Krishnan, MD; Meletios Athanasios (Thanos) C. Dimopoulos, MD; Shaji Kumar, MD; Katja Weisel, MD

Virtual Event

Washington State Medical Oncology Society

2 Sessions are Available!

Multimedia

Imaging Matters: Decoding PSMA PET for Better Decision-Making

Jeremie Calais, MD, PhD; Tanya B. Dorff, MD; Scott T. Tagawa, MD, MS, FACP, FASCO

$(CPE Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas$

Video

(CPE Track) Community Oncology Connections™: Leveraging Recent Advances in the Treatment of Relapsed/Refractory Follicular Lymphoma – Arkansas

Lori A. Leslie, MD; Alex Mejia, MD

Case-based Simulation

SimulatEd™: Partnering for Precision – A Framework for Personalized Care Planning in Acute Lymphoblastic Leukemia

Jae Park, MD

Video

9th Annual School of Nursing Oncology™

Beth Faiman, PhD, MSN, APN-BC, BMTCN, AOCN, FAAN, FAPO; Beth Sandy, MSN, CRNP, FAPO; Lindsay Adkins, MSN, FNP-BC, BMTCN; Jeneth Aquino, DNP, FNP-BC; Casey Gormley, MSN, FNP-C, AOCNP; Heather J. Jackson, PhD, FNP-BC; Kelsey Martin, AG-ACNP-BC, AOCNP; Nerina T. McDonald, PA-C; Lauren Verity Moore, DNP, MSN, AGACNP-BC; Faith A. Mutale, DNP, CRNP; Tiffany Richards, PhD, ANP-BC, AOCNP; Emily Skotte, DNP, MSN, ACNP-BC; Leslie Smith, DNP, RN, APRN-CNS, AOCNS, BMTCN; Saneese Stephen, PA-C, MPAS; Sara M. Tinsley-Vance, PhD, APRN, AOCN

Video

Cases and Conversations™: Optimizing Outcomes in PV and ET—Evolving Standards, Symptom Management, and Therapeutic Innovation

John O. Mascarenhas, MD; Marina Kremyanskaya, MD, PhD; Douglas A. Tremblay, MD

More News

Around the Helix: Cell and Gene Therapy Company Updates – April 22, 2026

ByNoah Stansfield

April 22nd 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 15, 2026

ByNoah Stansfield

April 15th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 8, 2026

ByNoah Stansfield

April 8th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – April 1, 2026

ByNoah Stansfield

April 1st 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 25, 2026

ByNoah Stansfield

March 25th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 18, 2026

ByNoah Stansfield

March 18th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 11, 2026

ByNoah Stansfield

March 11th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – March 4, 2026

ByNoah Stansfield

March 4th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 25, 2026

ByNoah Stansfield

February 25th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 18, 2026

ByNoah Stansfield

February 18th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind – February 13, 2026

ByNoah Stansfield

February 13th 2026

Review top news and interview highlights from the week ending February 13, 2026.

Around the Helix: Cell and Gene Therapy Company Updates – February 11, 2026

ByNoah Stansfield

February 11th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

Around the Helix: Cell and Gene Therapy Company Updates – February 4, 2026

ByNoah Stansfield

February 4th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind – January 30, 2026

ByNoah Stansfield

January 30th 2026

Review top news and interview highlights from the week ending January 30, 2026.

Around the Helix: Cell and Gene Therapy Company Updates – January 28, 2026

ByNoah Stansfield

January 28th 2026

Catch up on the latest news, breakthroughs, and announcements from biotechnology companies making advancements in cell and gene therapies.

CGTLive®’s Weekly Rewind – January 23, 2026

ByNoah Stansfield

January 23rd 2026

Review top news and interview highlights from the week ending January 23, 2026.

Jeffrey Goldberg, MD, PhD, a professor and chair of ophthalmology at the Byers Eye Institute at Stanford University

Jeffrey Goldberg, MD, PhD, on the Potential of Cell and Gene Therapy in Glaucoma

ByJeffrey Goldberg, MD, PhD,Noah Stansfield

January 22nd 2026

For Glaucoma Awareness Month, CGTLive® interviewed the chair of ophthalmology at the Byers Eye Institute at Stanford University about the potential of cell and gene therapy for the condition.